Aralez pharmaceuticals inc. (ARLZ)
Income statement / Yearly
Dec'17Dec'16
Revenues:
Product revenues, net

38,729

25,432

Other revenues

67,218

28,838

Total revenues, net

105,947

54,270

Product
Other
Costs and expenses:
Cost of product revenues (exclusive of amortization shown separately below)

13,506

11,765

Selling, general and administrative

116,572

118,548

Research and development

2,324

8,832

Amortization of intangible assets

34,323

12,591

Change in fair value of contingent consideration

35,725

750

Impairment of intangible assets

-

4,368

Total costs and expenses

202,450

156,854

Loss from operations

-96,503

-102,584

Interest expense

26,984

6,141

Other income (expense), net

682

5,683

Loss before income taxes

-122,805

-103,042

Income tax expense (benefit)

2,400

-64

Net loss

-125,205

-102,978

Basic net loss per common share (in dollars per share)

-1.89

-1.67

Diluted net loss per common share (in dollars per share)

-1.89

-1.74

Shares used in computing basic net loss per common share

66,389

61,831

Shares used in computing diluted net loss per common share

66,389

61,883